Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled time : 13:05 save search
Replimune Announces First Patient Dosed with RP3 in a Phase 1 Clinical Trial in Patients with Advanced Solid Tumors
Published: 2021-01-05 (Crawled : 13:05) - globenewswire.com
REPL | $6.43 -0.31% -0.31% 550K
|
Health Technology
|
| O: -1.78%
H: 5.19%
C: 2.61%
trial phase 3 phase 1 phase 2 solid tumors
Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome
Published: 2020-12-17 (Crawled : 13:05) - globenewswire.com
ALBO | $44.15 -0.23% 0.39% 1.2M
|
Health Technology
|
| O: -0.48%
H: 3.19%
C: -0.94%
phase 3 trial syndros
Kiniksa Commences Dosing of Vixarelimab Phase 2b Clinical Trial in Prurigo Nodularis
Published: 2020-12-15 (Crawled : 13:05) - globenewswire.com
KNSA | $17.11 1.18% 1.17% 360K
|
Health Technology
|
| O: -0.03%
H: 5.24%
C: 0.56%
trial phase 2b vixarelimab
BioCardia Anticipates DSMB Feedback on Interim Data From Pivotal Phase 3 CardiAMP Heart Failure Trial
Published: 2020-12-14 (Crawled : 13:05) - globenewswire.com
BCDA P | $0.351 -2.5% -2.56% 51K
|
Health Technology
|
| O: 10.28%
H: 123.47%
C: 44.05%
heart phase 3 trial cardiamp
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its ALK2 Inhibitor Program, Including KER-047 Phase 1 Data, and KER-050 Preclinical Data, at the Virtual 62nd American Society of Hematology Annual Meeting and Exposition
Published: 2020-12-07 (Crawled : 13:05) - globenewswire.com
KROS | $55.845 -4.18% -4.36% 280K
|
Health Technology
|
| O: -0.36%
H: 2.91%
C: -2.8%
results trial phase 3 phase 1 phase 2 preclinical pre-clinical
Daré Bioscience Announces Positive Topline Results From DARE-BVFREE, a Phase 3 Trial of DARE-BV1 in Patients Diagnosed with Bacterial Vaginosis
Published: 2020-12-07 (Crawled : 13:05) - globenewswire.com
DARE | $0.2932 4.71% 4.5% 150K
|
Health Technology
|
| O: -6.0%
H: 2.84%
C: -5.67%
positive results phase 3 trial topline
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.